MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Anthera Pharmaceuticals (NASDAQ: ANTH)
Organization & Developments: Anthera
Parents
Anthera Pharmaceuticals (NASDAQ: ANTH)
Children
2011: Anthera Raises $47M (2011)
2016: Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3
Acute Chest Syndrome
Acute Coronary Syndrome
Acute Lung Injury
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation
Anti-inflammatory products which have the potential to address a variety of inflammatory diseases including:
Atherosclerosis
Psoriasis
Jumps
*Key People: Anthera
Finance & Acquisitions: Anthera